Yuhan Corporation

000100.KS · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

123,250 KRW (≈ 86.28 USD)

Margin of Safety

+43.3 %

Rating

BEOBACHTEN

Yuhan Corporation is a South Korean pharmaceutical manufacturer that generates revenues from prescription specialty pharmaceuticals, generics, as well as nutritional supplements and consumer goods products, with regulatory approvals and patent portfolios forming the essential revenue drivers.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.